BLT benitec biopharma limited

xmas 2015, page-22

  1. 1,101 Posts.
    Hoyland we our hep c program maybe worth 1b at xmas 2015.
    What about the tech itself. With HIV cured, hep b, lung cancer trial underway and many other trials all doong great with OUR tech. How could we not be worth 10b by that time?

    Pharmasset paid 11b for one program in a P1!!
    Gilead wont want our competition will pay up.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.